CO4910166A1 - Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptores - Google Patents

Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptores

Info

Publication number
CO4910166A1
CO4910166A1 CO97068615A CO97068615A CO4910166A1 CO 4910166 A1 CO4910166 A1 CO 4910166A1 CO 97068615 A CO97068615 A CO 97068615A CO 97068615 A CO97068615 A CO 97068615A CO 4910166 A1 CO4910166 A1 CO 4910166A1
Authority
CO
Colombia
Prior art keywords
hydrogen
compounds
imidazolinylaminindazole
compounds useful
alkanyl
Prior art date
Application number
CO97068615A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Lee Cupps
Sophie Eva Bogdan
Raymond Todd Henry
Russell James Sheldon
William Lee Seibel
Jeffrey Joseph Ares
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO4910166A1 publication Critical patent/CO4910166A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
CO97068615A 1996-11-25 1997-11-24 Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptores CO4910166A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25

Publications (1)

Publication Number Publication Date
CO4910166A1 true CO4910166A1 (es) 2000-04-24

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97068615A CO4910166A1 (es) 1996-11-25 1997-11-24 Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptores

Country Status (20)

Country Link
EP (1) EP0944620A1 (fr)
JP (1) JP2001506599A (fr)
KR (1) KR20000069104A (fr)
CN (1) CN1244864A (fr)
AR (1) AR010643A1 (fr)
AU (1) AU5433998A (fr)
BR (1) BR9713535A (fr)
CA (1) CA2272644A1 (fr)
CO (1) CO4910166A1 (fr)
CZ (1) CZ183999A3 (fr)
HU (1) HUP9904660A3 (fr)
ID (1) ID22676A (fr)
IL (1) IL130067A0 (fr)
NO (1) NO992502L (fr)
NZ (1) NZ335882A (fr)
PE (1) PE47099A1 (fr)
SK (1) SK69699A3 (fr)
TR (1) TR199901542T2 (fr)
WO (1) WO1998023609A1 (fr)
ZA (1) ZA9710576B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
US20100311965A1 (en) 2007-12-28 2010-12-09 Carna Biosciences Inc. 2-aminoquinazoline derivative
WO2010074753A1 (fr) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Dispositifs d'inhalation et procédés associés pour administration de composés hypnotiques sédatifs
CN112538074A (zh) * 2020-12-24 2021-03-23 艾希尔（深圳）药物研发有限公司 一种溴莫尼定脱溴杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
ATE194771T1 (de) * 1993-12-17 2000-08-15 Procter & Gamble 6-(2-imidazolinylamino) chinoxalin-verbindungen als alpha-2-adrenorezeptoragonisten

Also Published As

Publication number Publication date
CA2272644A1 (fr) 1998-06-04
CZ183999A3 (cs) 1999-11-17
NO992502L (no) 1999-07-26
PE47099A1 (es) 1999-06-12
EP0944620A1 (fr) 1999-09-29
NZ335882A (en) 2000-12-22
AU5433998A (en) 1998-06-22
JP2001506599A (ja) 2001-05-22
IL130067A0 (en) 2000-02-29
TR199901542T2 (xx) 2000-01-21
WO1998023609A1 (fr) 1998-06-04
ID22676A (id) 1999-12-09
AR010643A1 (es) 2000-06-28
NO992502D0 (no) 1999-05-25
SK69699A3 (en) 2000-06-12
HUP9904660A3 (en) 2002-02-28
ZA9710576B (en) 1998-09-16
BR9713535A (pt) 2000-03-21
KR20000069104A (ko) 2000-11-25
CN1244864A (zh) 2000-02-16
HUP9904660A2 (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
CO4910149A1 (es) Compuestos de 2-imidazolinilaminoindol utiles como agonistas de alfa-2 adrenoceptores
CO4910148A1 (es) Compuestos heterociclicos de guanidinilo utiles como agonis- tas de alfa-2 adrenoceptores
AR002955A1 (es) Un compuesto heterocíclico substituido, procedimiento y compuestos intermediarios para su preparación y composición farmacéutica que contiene a dicho compuesto.
AR036114A1 (es) Tetrahidroimidazol[1,2-a]pirazinas y tetrahidrotriazol[4,3-a]pirazinas como inhibidores de la dipeptidil peptidasa utiles para el tratamiento o la prevencion de la diabetes
AR040773A1 (es) Pirazoles utiles como inhibidores de gsk-3
CO5700824A2 (es) Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen
AR059895A1 (es) Derivados biciclicos de acidos carboxilicos que resultan de utilidad para tratar trastornos metabolicos
AR067663A1 (es) Derivados heterociclicos de etiloxi amidas, composiciones que los comprenden y usos de los mismos en agricultura u horticultura, como agentes antifungicos.
MX9300031A (es) Derivados de piperazina, procedimiento para su preparacion y composicion farmaucetica que los contiene.
CO5160347A1 (es) Derivados de acido carbamico
AR018186A1 (es) Compuestos de carbazoly de 1,2,3,4-tetrahidrocarbazol sustituidos, utiles como inhibidores de la liberacion de acidos grasos mediada por spla2,procedimiento para prepararlos; compuestos intermediarios de aplicacion en dichos procedimientos; composiciones farmaceuticas que comprenden dichos compuesto
AR026352A1 (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
CO4910150A1 (es) Compuestos de 2-imidazolinilaminobenzoxazol utiles con agonistas de alfa-2 adrenoceptores
CO5050366A1 (es) Compuesto fungicida correspondiente a compuesto 7-bromo-3- metil-3,4-dihidrotienol[3,2-d]pirimidin-4-ona
AR022019A1 (es) Un compuesto de imidazol y las composiciones farmaceuticas que lo contienen
AR002690A1 (es) Derivado de bencimidazol o sales del mismo, composicion farmaceutica, agente inmunosupresor y agente antiinflamatorio que lo contienen yprocedimientos para preparar dicho derivado.
NZ513594A (en) Heterocyclic compounds, intermediates thereof and elastase inhibitors
CO4910166A1 (es) Compuestos 2-imidazolinilaminoindazol utiles como agonistas de 2-alfa adrenoceptores
PE78898A1 (es) Derivados de 2,4-diaminopirimidinas
ES2249636T3 (es) Triazoles como antagonistas de la oxitocina.
CO4910168A1 (es) Compuestos de 2-imidazolinilaminobenzotiazol utiles como agonistas de alfa-2 adrenoceptores
DE69528978D1 (de) Lactamverbindungen als Inhibitoren der Cholesterin-Esterase
CO4910167A1 (es) Compuestos heterociclicos de guanidinilamino utiles como agonistas de alfa-2 adrenoceptores
CA2272098A1 (fr) Composes heterocycliques guanidinylamino utiles en tant qu'agonistes de l'adrenorecepteur alpha-2
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.